F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy
Authors:
- S. ChanteauSCS. Chanteau
- L. RabarijaonaLRL. Rabarijaona
- T. O'BRienTOT. O'BRien
- L. RahalisonLRL. Rahalison
- J. HagerJHJ. Hager
- P. BoisieiPBP. Boisiei
- J. BuransJBJ. Burans
- M. RasolomaharoMRM. Rasolomaharo
- 1 September 1998
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 92 (5) , 572-573
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Plague, a Reemerging Disease in MadagascarEmerging Infectious Diseases, 1998
- Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in MadagascarClinical and Diagnostic Laboratory Immunology, 1997
- Urban epidemic of bubonic plague in Majunga, Madagascar: epidemiological aspectsTropical Medicine & International Health, 1997
- The Genus Yersinia: Biochemistry and Genetics of Virulence With 3 Figures1972